Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02007200 · FLOW

Participant flow

Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery · Source last updated 2016-10-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Patients receive soy isoflavones PO for approximately 14 days before undergoing surgery. 55 patients were enrolled. 3 of these patients did not receive treatment.
    id
    FG000
    title
    Treatment (Soy Isoflavones)
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        55
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        55
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Patients receive soy isoflavones PO for approximately 14 days before undergoing surgery. 55 patients were enrolled. 3 of these patients did not receive treatment.
    id
    FG000
    title
    Treatment (Soy Isoflavones)
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        55
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        55
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice